Atorvastatin Calcium Tablets — Class II drug recall D-0113-2027
Ongoing recall by MSN Laboratories Private Limited (Formulations Division, Unit-II), reported 2026-11-04, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0113-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | MSN Laboratories Private Limited (Formulations Division, Unit-II), Rangareddy District, India |
| Recall initiated | 2026-10-21 |
| Classified | 2026-10-29 |
| Reported by FDA | 2026-11-04 |
| Distributed | Nationwide (US) |
| NDC | 72205-0022, 72205-0022-05, 72205-0022-30, 72205-0022-90, 72205-0022-99, 72205-0023, 72205-0023-05, 72205-0023-30, 72205-0023-90, 72205-0023-99, 72205-0024, 72205-0024-05, 72205-0024-30, 72205-0024-90, 72205-0024-99, 72205-0025, 72205-0025-05, 72205-0025-30, 72205-0025-90, 72205-0025-99 |
| Lot numbers | DRF09618A, DRG02110A |
| Expiration dates | 2029-08-31, 2030-01-31 |
Product
Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0113-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.